ASP Isotopes CEO Paul Mann to Return From Medical Leave

Dow Jones12-02

By Colin Kellaher

ASP Isotopes co-founder Paul Mann will return to the helm of the advanced-materials company early next year after a medical leave of absence.

ASP on Tuesday said Mann, who stepped aside as chief executive of the Washington-based company earlier this year following orthopaedic surgery, is now able to travel again and will resume full day-to-day CEO duties on Jan. 19.

He will also continue as executive chairman, ASP said.

ASP said Robert Ainscow, who co-founded the company with Mann and has been serving as interim CEO, will continue as chief operating officer.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

December 02, 2025 09:49 ET (14:49 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588512130?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 22:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588512130","market":"nz","top_or_hot":-1,"title":"ASP Isotopes CEO Paul Mann to Return From Medical Leave","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ASPI\">ASP Isotopes</a> co-founder Paul Mann will return to the helm of the advanced-materials company early next year after a medical leave of absence. \n</p>\n<p>\n  ASP on Tuesday said Mann, who stepped aside as chief executive of the Washington-based company earlier this year following  orthopaedic surgery, is now able to travel again and will resume full day-to-day CEO duties on Jan. 19. \n</p>\n<p>\n  He will also continue as executive chairman, ASP said. \n</p>\n<p>\n  ASP said Robert Ainscow, who co-founded the company with Mann and has been serving as interim CEO, will continue as chief operating officer. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) <a href=\"https://laohu8.com/S/DOW\">Dow</a> Jones Newswires\n</p>\n<p>\n  December 02, 2025 09:49 ET (14:49 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASP Isotopes CEO Paul Mann to Return From Medical Leave</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASP Isotopes CEO Paul Mann to Return From Medical Leave\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-02 22:49</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ASPI\">ASP Isotopes</a> co-founder Paul Mann will return to the helm of the advanced-materials company early next year after a medical leave of absence. \n</p>\n<p>\n  ASP on Tuesday said Mann, who stepped aside as chief executive of the Washington-based company earlier this year following  orthopaedic surgery, is now able to travel again and will resume full day-to-day CEO duties on Jan. 19. \n</p>\n<p>\n  He will also continue as executive chairman, ASP said. \n</p>\n<p>\n  ASP said Robert Ainscow, who co-founded the company with Mann and has been serving as interim CEO, will continue as chief operating officer. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) <a href=\"https://laohu8.com/S/DOW\">Dow</a> Jones Newswires\n</p>\n<p>\n  December 02, 2025 09:49 ET (14:49 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4109","symbol_name":"特种化学制品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2588512130","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588512130","pubTimestamp":1764686940,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"ASP Isotopes co-founder Paul Mann will return to the helm of the advanced-materials company early next year after a medical leave of absence.ASP on Tuesday said Mann, who stepped aside as chief executive of the Washington-based company earlier this year following  orthopaedic surgery, is now able to travel again and will resume full day-to-day CEO duties on Jan. 19.He will also continue as executive chairman, ASP said.ASP said Robert Ainscow, who co-founded the company with Mann and has been serving as interim CEO, will continue as chief operating officer.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4109":"特种化学制品","ASPI":"ASP Isotopes Inc."},"translate_title":"ASP Isotopes首席执行官Paul Mann将病假归来","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASPI":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\nASP Isotopes co-founder Paul Mann will return to the helm of the advanced-materials company early next year after a medical leave of absence. \n\n\n  ASP on Tuesday said Mann, who stepped aside as chief executive of the Washington-based company earlier this year following  orthopaedic surgery, is now able to travel again and will resume full day-to-day CEO duties on Jan. 19. \n\n\n  He will also continue as executive chairman, ASP said. \n\n\n  ASP said Robert Ainscow, who co-founded the company with Mann and has been serving as interim CEO, will continue as chief operating officer. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 09:49 ET (14:49 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588512130","isCrawlerRequest":true}